Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Atp5mc2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of ATP5MC2 mRNA | CTD | PMID:22206623 | Atp5mc2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ATP5MC2 mRNA | CTD | PMID:32109520 | Atp5mc2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP5MC2 mRNA | CTD | PMID:33387578 | Atp5mc2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP5MC2 mRNA | CTD | PMID:20399798 | Atp5mc2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP5MC2 mRNA | CTD | PMID:21570461 | Atp5mc2 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATP5MC2 mRNA | CTD | PMID:20188158 | Atp5mc2 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Atp5mc2 (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of ATP5MC2 mRNA | CTD | PMID:30951980 | Atp5mc2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ATP5MC2 mRNA | CTD | PMID:39298647 | Atp5mc2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ATP5MC2 mRNA | CTD | PMID:28973697 | Atp5mc2 | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of ATP5MC2 mRNA | CTD | PMID:31881176 | Atp5mc2 | Rat | aflatoxin B1 | increases methylation | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of ATP5MC2 gene | CTD | PMID:27153756 | Atp5mc2 | Rat | all-trans-retinoic acid | decreases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ATP5MC2 mRNA | CTD | PMID:21934132 | Atp5mc2 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Atp5mc2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of ATP5MC2 mRNA; [bisphenol S co-treated more ... | CTD | PMID:30951980 | Atp5mc2 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ATP5MC2 mRNA | CTD | PMID:16483693 | Atp5mc2 | Rat | arsane | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATP5MC2 more ... | CTD | PMID:39836092 | Atp5mc2 | Rat | arsenic atom | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATP5MC2 more ... | CTD | PMID:39836092 | Atp5mc2 | Rat | arsenite(3-) | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | arsenite results in decreased expression of ATP5MC2 mRNA | CTD | PMID:33053406 | Atp5mc2 | Rat | arsenite(3-) | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to ATP5MC2 mRNA] | CTD | PMID:32406909 | Atp5mc2 | Rat | arsenous acid | multiple interactions | ISO | Atp5mc2 (Mus musculus) | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of ATP5MC2 mRNA] | CTD | PMID:29095437 | Atp5mc2 | Rat | arsenous acid | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of ATP5MC2 mRNA | CTD | PMID:29095437 | Atp5mc2 | Rat | benzo[a]pyrene | increases methylation | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ATP5MC2 promoter | CTD | PMID:27901495 | Atp5mc2 | Rat | benzo[a]pyrene | decreases methylation | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ATP5MC2 exon | CTD | PMID:27901495 | Atp5mc2 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of ATP5G2 more ... | CTD | PMID:33872906 | Atp5mc2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ATP5MC2 mRNA | CTD | PMID:25181051 | Atp5mc2 | Rat | bisphenol A | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ATP5MC2 mRNA | CTD | PMID:33221593 | Atp5mc2 | Rat | bisphenol A | multiple interactions | ISO | Atp5mc2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of ATP5MC2 mRNA | CTD | PMID:30951980 | Atp5mc2 | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of ATP5MC2 mRNA | CTD | PMID:19167457 | Atp5mc2 | Rat | CGP 52608 | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ATP5MC2 gene] | CTD | PMID:28238834 | Atp5mc2 | Rat | chlorpyrifos | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ATP5MC2 mRNA | CTD | PMID:37019170 | Atp5mc2 | Rat | clobetasol | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Clobetasol results in increased expression of ATP5MC2 mRNA | CTD | PMID:27462272 | Atp5mc2 | Rat | copper(II) sulfate | decreases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ATP5MC2 mRNA | CTD | PMID:19549813 | Atp5mc2 | Rat | crocidolite asbestos | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Asbestos, Crocidolite results in decreased expression of ATP5MC2 mRNA | CTD | PMID:29279043 | Atp5mc2 | Rat | diarsenic trioxide | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of ATP5MC2 mRNA | CTD | PMID:29095437 | Atp5mc2 | Rat | diarsenic trioxide | multiple interactions | ISO | Atp5mc2 (Mus musculus) | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of ATP5MC2 mRNA] | CTD | PMID:29095437 | Atp5mc2 | Rat | disodium selenite | increases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of ATP5MC2 mRNA | CTD | PMID:18175754 | Atp5mc2 | Rat | doxorubicin | increases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of ATP5MC2 mRNA | CTD | PMID:29803840 | Atp5mc2 | Rat | fenthion | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Fenthion results in increased expression of ATP5MC2 mRNA | CTD | PMID:34813904 | Atp5mc2 | Rat | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of ATP5MC2 mRNA | CTD | PMID:17341692 | Atp5mc2 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ATP5MC2 mRNA | CTD | PMID:22061828 | Atp5mc2 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ATP5MC2 mRNA | CTD | PMID:33387578 | Atp5mc2 | Rat | ketoconazole | increases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Ketoconazole results in increased expression of ATP5MC2 mRNA | CTD | PMID:36621641 | Atp5mc2 | Rat | lead(0) | affects expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Lead affects the expression of ATP5MC2 mRNA | CTD | PMID:28903495 | Atp5mc2 | Rat | lipopolysaccharide | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MC2 mRNA | CTD | PMID:31059760 | Atp5mc2 | Rat | metformin | multiple interactions | ISO | Atp5mc2 (Mus musculus) | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of ATP5MC2 mRNA] | CTD | PMID:29095437 | Atp5mc2 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of ATP5G2 more ... | CTD | PMID:33872906 | Atp5mc2 | Rat | nitrates | multiple interactions | ISO | Atp5mc2 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ATP5MC2 more ... | CTD | PMID:35964746 | Atp5mc2 | Rat | okadaic acid | decreases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of ATP5MC2 mRNA | CTD | PMID:38832940 | Atp5mc2 | Rat | oxybenzone | decreases expression | EXP | | 6480464 | oxybenzone results in decreased expression of ATP5MC2 mRNA | CTD | PMID:30316929 | Atp5mc2 | Rat | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of ATP5MC2 mRNA | CTD | PMID:32991914 | Atp5mc2 | Rat | paracetamol | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MC2 mRNA | CTD | PMID:31059760 | Atp5mc2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ATP5MC2 mRNA | CTD | PMID:33387578 | Atp5mc2 | Rat | paracetamol | decreases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ATP5MC2 mRNA | CTD | PMID:31059760 | Atp5mc2 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ATP5MC2 mRNA | CTD | PMID:20936131 | Atp5mc2 | Rat | poly(vinylpyrrolidone) | multiple interactions | EXP | | 6480464 | [Silver analog co-treated with Povidone] results in decreased expression of ATP5MC2 mRNA | CTD | PMID:25194297 | Atp5mc2 | Rat | resveratrol | increases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Resveratrol results in increased expression of ATP5MC2 mRNA | CTD | PMID:22610192 | Atp5mc2 | Rat | silicon dioxide | decreases expression | ISO | Atp5mc2 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of ATP5MC2 mRNA | CTD | PMID:19073995 | Atp5mc2 | Rat | silver atom | multiple interactions | EXP | | 6480464 | [Silver analog co-treated with Povidone] results in decreased expression of ATP5MC2 mRNA | CTD | PMID:25194297 | Atp5mc2 | Rat | silver(0) | multiple interactions | EXP | | 6480464 | [Silver analog co-treated with Povidone] results in decreased expression of ATP5MC2 mRNA | CTD | PMID:25194297 | Atp5mc2 | Rat | sodium arsenite | decreases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ATP5MC2 mRNA | CTD | PMID:38568856 | Atp5mc2 | Rat | sodium arsenite | multiple interactions | ISO | ATP5MC2 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATP5MC2 more ... | CTD | PMID:39836092 | Atp5mc2 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of ATP5MC2 mRNA | CTD | PMID:34492290 | Atp5mc2 | Rat | titanium dioxide | decreases methylation | ISO | Atp5mc2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ATP5G2 gene | CTD | PMID:35295148 | Atp5mc2 | Rat | triphenyl phosphate | affects expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ATP5MC2 mRNA | CTD | PMID:37042841 | Atp5mc2 | Rat | valproic acid | decreases expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ATP5MC2 mRNA | CTD | PMID:23179753|PMID:29501571 | Atp5mc2 | Rat | valproic acid | affects expression | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ATP5MC2 mRNA | CTD | PMID:25979313 | Atp5mc2 | Rat | valproic acid | increases methylation | ISO | ATP5MC2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ATP5MC2 gene | CTD | PMID:29501571 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















